Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.5300
+0.0500 (3.38%)
NASDAQ · Last Trade: Nov 4th, 11:31 AM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors